Cargando…

mTOR: A possible therapeutic target against SARS-CoV-2 infection

Detalles Bibliográficos
Autor principal:	Khan, Nabab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225252/ https://www.ncbi.nlm.nih.gov/pubmed/34179893

Ejemplares similares

Possible therapeutic targets for SARS-CoV-2 infection and COVID-19
por: Khan, Nabab, et al.
Publicado: (2021)

Therapeutic role of mTOR inhibitors in control of SARS-CoV-2 viral replication
por: Khalid, Tuba, et al.
Publicado: (2022)

Engineered extracellular vesicles antagonize SARS-CoV-2 infection by inhibiting mTOR signaling
por: Ibrahim, A.G., et al.
Publicado: (2022)

Increased mTOR Signaling and Impaired Autophagic Flux Are Hallmarks of SARS-CoV-2 Infection
por: Zambalde, Érika Pereira, et al.
Publicado: (2022)

mTOR: An attractive therapeutic target for osteosarcoma?
por: Ding, Liu, et al.
Publicado: (2016)

EGFR and mTOR as therapeutic targets in glioblastoma
por: Ronellenfitsch, Michael W., et al.
Publicado: (2019)

mTOR: A Potential Therapeutic Target in Osteoarthritis?
por: Pal, Bandna, et al.
Publicado: (2015)

Targeting mTOR as a Therapeutic Approach in Medulloblastoma
por: Aldaregia, Juncal, et al.
Publicado: (2018)

mTOR Signaling and Potential Therapeutic Targeting in Meningioma
por: Pinker, Benjamin, et al.
Publicado: (2022)

PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy
por: Fattahi, Soheila, et al.
Publicado: (2022)

Possible Therapeutic Use of Natural Compounds Against COVID-19
por: Khan, Nabab, et al.
Publicado: (2021)

mTOR Signaling Cascade in Psoriatic Disease: Double Kinase mTOR Inhibitor a Novel Therapeutic Target
por: Raychaudhuri, Smriti K, et al.
Publicado: (2014)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

The Role of mTOR Signaling as a Therapeutic Target in Cancer
por: Popova, Nadezhda V., et al.
Publicado: (2021)

mTOR pathway – a potential therapeutic target in stroke
por: Melanis, Konstantinos, et al.
Publicado: (2023)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
por: Appelberg, Sofia, et al.
Publicado: (2020)

mTOR Kinase: A Possible Pharmacological Target in the Management of Chronic Pain
por: Lisi, Lucia, et al.
Publicado: (2015)

Targeting mTOR for cancer therapy
por: Hua, Hui, et al.
Publicado: (2019)

Targeting ganglioneuromas with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2021)

Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
por: Evangelisti, Camilla, et al.
Publicado: (2018)

Therapeutic Targeting of Innate Immune Receptors Against SARS-CoV-2 Infection
por: Farooq, Mariya, et al.
Publicado: (2022)

Possible protective role of 17β-estradiol against COVID-19
por: Khan, Nabab
Publicado: (2020)

Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route
por: de Oliveira, Ana Patrícia, et al.
Publicado: (2020)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

mTOR co-targeting strategies for head and neck cancer therapy
por: Wang, Zhiyong, et al.
Publicado: (2017)

Co-Targeting FASN and mTOR Suppresses Uveal Melanoma Growth
por: Han, Anna, et al.
Publicado: (2023)

Ganglioneuromas are driven by activated AKT and can be therapeutically targeted with mTOR inhibitors
por: Tao, Ting, et al.
Publicado: (2020)

mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
por: Babicheva, Aleksandra, et al.
Publicado: (2021)

mTOR kinase is a therapeutic target for respiratory syncytial virus and coronaviruses
por: Huynh, HoangDinh, et al.
Publicado: (2021)

The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
por: Platé, Manuela, et al.
Publicado: (2020)

Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment
por: Singh, Shilpi, et al.
Publicado: (2023)

Targeting mTOR dependency in pancreatic cancer
por: Morran, Douglas C, et al.
Publicado: (2014)

Targeting mTOR in Pancreatic Ductal Adenocarcinoma
por: Iriana, Sentia, et al.
Publicado: (2016)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma
por: Folgiero, Valentina, et al.
Publicado: (2016)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection
por: Mandato, Claudia, et al.
Publicado: (2021)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
por: Kang, Michael Yoon, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_t0pj8bebh5dhru36u36rs6mftn